BETA


2022/2977(DEA) Inclusion of certain drug precursors in the list of scheduled substances

Progress: Procedure completed - delegated act enters into force

RoleCommitteeRapporteurShadows
Lead LIBE
Lead committee dossier:

Events

2023/03/07
   European Commission - Document attached to the procedure
Documents
2023/02/02
   EP - Delegated act not objected by Parliament
2022/12/14
   EP - Committee referral announced in Parliament
2022/11/25
   European Commission - Non-legislative basic document
Documents
2022/11/25
   EC - Non-legislative basic document published
Documents
2022/11/25
   Initial period for examining delegated act 2.0 month(s)

Documents

  • Document attached to the procedure: C(2023)1654
  • Non-legislative basic document: C(2022)08440
  • Non-legislative basic document published: C(2022)08440
  • Non-legislative basic document: C(2022)08440
  • Document attached to the procedure: C(2023)1654

History

(these mark the time of scraping, not the official date of the change)

docs/0/body
Old
EC
New
European Commission
docs/1/body
Old
EC
New
European Commission
events/1
date
2022-11-25T00:00:00
type
Initial period for examining delegated act 2.0 month(s)
events/1
date
2022-11-25T00:00:00
type
Initial period for examining delegated act 2 month(s)
body
EP/CSL
procedure/dossier_of_the_committee
Old
  • LIBE/9/10787
New
LIBE/9/10787
procedure/subtype
Old
Examination of delegated act
New
  • Examination of delegated act
  • Supplementing
  • 2002/0217(COD)
docs/1
date
2023-03-07T00:00:00
docs
title: C(2023)1654
type
Document attached to the procedure
body
EC
events/3
date
2023-02-02T00:00:00
type
Delegated act not objected by Parliament
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Procedure completed - delegated act enters into force
events/2
date
2022-12-14T00:00:00
type
Committee referral announced in Parliament
body
EP
procedure/dossier_of_the_committee
  • LIBE/9/10787
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision